Related Experiment Video
Updated: Feb 7, 2026

Malachite Green Assay for the Discovery of Heat-Shock Protein 90 Inhibitors
Published on: January 20, 2023
Simvastatin functions as a heat shock protein 90 inhibitor against triple-negative breast cancer
Xinhui Kou1,2, Xiaoxiao Jiang2, Huijuan Liu2
1Department of Endocrine and Department of Pharmacy, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, China.
Abstract:
Acetylation plays an important role in regulating the chaperone activity of heat shock protein 90 (Hsp90) during malignant transformation through the stabilization and conformational maturation of oncogenic proteins. However, the functional acetylation sites, potential anticancer drug targets, are still emerging. We found that acetylation at K292 in Hsp90α is critical for the development and treatment of breast cancer. Acetylation at K292 not only augments the affinity of Hsp90 to ATP, cochaperones, and client proteins but it also promotes cancer cell colony formation, migration, and invasion in vitro as well as tumor growth in vivo. Importantly, K292-acetylated Hsp90 has been validated as an exciting anticancer drug target by interfering with the complex formation between K292-acetylated Hsp90 and cochaperone Cdc37, leading to diminishment of kinase client maturation and proteasome-dependent degradation of kinase substrates. Furthermore, we showed that simvastatin prevented, whereas LBH589 promoted, the progression of Hsp90 chaperone cycling and client maturation, resulting in an increment of cell apoptosis by the combination of simvastatin and LBH589 in a mouse xenograft model. These data suggest that simvastatin is a novel Hsp90 inhibitor to disrupt the formation of the K292-acetylated Hsp90/Cdc37 complex in triple-negative breast cancer cells. The combination of simvastatin with LBH589 could be used as a novel therapeutic strategy for triple-negative breast cancer.
Insights
Acetylation at K292 in heat shock protein 90 (Hsp90) drives breast cancer progression. Targeting this site with simvastatin and LBH589 offers a novel therapeutic strategy for triple-negative breast cancer.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Heat shock protein 90 (Hsp90) acetylation regulates chaperone activity crucial for malignant transformation.
- Identifying functional acetylation sites on Hsp90 is key for developing novel anticancer drugs.
Purpose of the Study:
- To investigate the role of K292 acetylation in Hsp90α in breast cancer development and treatment.
- To validate K292-acetylated Hsp90 as an anticancer drug target.
- To explore the therapeutic potential of combining simvastatin and LBH589 for triple-negative breast cancer.
Main Methods:
- Investigated the impact of K292 acetylation on Hsp90 affinity for ATP, cochaperones, and client proteins.
- Assessed the effects of K292 acetylation on cancer cell proliferation, migration, and invasion in vitro.
- Evaluated tumor growth in vivo using a mouse xenograft model.
- Examined the mechanism of action of simvastatin and LBH589 on Hsp90 acetylation and client maturation.
Main Results:
- Acetylation at K292 in Hsp90α enhances Hsp90 binding to ATP, cochaperones, and client proteins, promoting cancer progression.
- K292-acetylated Hsp90 is a viable drug target, with disruption of the Hsp90/Cdc37 complex leading to client degradation.
- Simvastatin inhibits K292-acetylated Hsp90/Cdc37 complex formation, while LBH589 promotes Hsp90 cycling.
- Combination therapy with simvastatin and LBH589 increased apoptosis in a triple-negative breast cancer xenograft model.
Conclusions:
- Acetylation at K292 of Hsp90α is critical for breast cancer progression and represents a promising therapeutic target.
- Simvastatin acts as a novel Hsp90 inhibitor by disrupting the K292-acetylated Hsp90/Cdc37 complex.
- The combination of simvastatin and LBH589 presents a novel therapeutic strategy for triple-negative breast cancer.
Related Concept Videos
Structural Protein Function
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity. In bones and teeth, it mineralizes to...
Responses to Heat and Cold Stress
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Negative Regulator Molecules
Mechanical Protein Functions
Gram-negative Bacterial Protein Secretion Systems

